Dendreon Corporation (DNDN)
News
| 10:43 AM | $DNDN http://stks.co/3zPs ak - its Now 2011 low was $6.46 but for a long ST would need good volume flag break by StockTiger |
| May 24 | $DNDN You have violated me for the last time $DNDN by CoolBreeze |
| May 24 | $VRTX $DNDN $HLF Do stock analysts really analyse anything? It seems their work is simply following flocks. No one should get paid for that! by mitrado |
| May 23 | @WolfpackInvest what are you in now? Me $CLDX $ARNA $IMUC.OB $DNDN the poor dog who everybody kicks including Karpal!! by bigbadbroker |
| May 23 | @bradloncar $dndn do u have the pass code ? by TraderPalmilla |
| May 23 | Notable Analyst Rating Changes 05/23: (SBUX) (AMAT) (WMB) Upgraded; (NDAQ) (PSO) (ARB... |
| May 23 | Canaccord Genuity Maintains a 'Hold' on Dendreon (DNDN) After Meeting with Management Street Insider |
| May 23 | UPDATE: Jefferies Starts Dendreon (DNDN) at Underperform, Sees 35% Downside Street Insider |
| May 22 | @ChasinCheddar Meanwhile, $LNKD trades with a P/E of 626.77. Is a Social Network better for the world than $DNDN's Provenge!? Insanity!! :-O by mitrado |
| May 22 | Jefferies Starts Dendreon (DNDN) at Underperform, Nektar (NKTR) at Buy Street Insider |
| May 22 | Sequenom's Brief, Wondrous Agreement Fool |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
Dendreon Corporation is a biotechnology company focused on targeting cancer and transforming lives through the discovery, development, commercialization, and manufacturing of novel therapeutics that may significantly improve cancer treatment options for patients. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response. Dendreon is headquartered in Seattle and has manufacturing facilities in New Jersey, Georgia, and California. The company was founded in 1992.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Dendreon Corporation is down 82.62% over the last year vs S&P 500 Total Return up 2.57%, Medivation up 271.9%, and Galena Biopharma up 2.78%.
- DNDN Total Returns
- ^SPXTR Total Returns
- MDVN Total Returns
- GALE Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these DNDN related companies
Pro Strategies Featuring DNDN
Did Dendreon Corporation make it into our Pro Portfolio Strategies?
DNDN Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other DNDN Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DNDN | 7.105 | -0.12 | -1.59% | 1.111B |
| DM | 6.95 | +0.08 | +1.16% | 199.99M |
| DLTR | 102.16 | +0.45 | +0.44% | 11.49B |
| DLN | 50.66 | -0.11 | -0.22% | |
| DLLR | 15.51 | -0.04 | -0.26% | 686.22M |
| DLIA | 1.50 | -0.01 | -0.66% | 47.77M |
| DLB | 43.95 | -0.05 | -0.11% | 4.772B |
| DL | 3.47 | +0.17 | +5.15% | 117.05M |
| DKA | 21.66 | -0.06 | -0.30% | |
| DK | 16.90 | +0.46 | +2.80% | 980.00M |
